Tandem Diabetes Care, Inc. (TNDM) Stock: Here’s Why It’s Declining


Tandem Diabetes Care, Inc. (TNDM) is falling in the market today. The company, one that is focused in the technology industry, is currently priced at $68.76 after falling -6.53% so far today. In terms of tech companies, there are several factors that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the recent trending headlines surrounding TNDM:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-18-19 12:43PM Jim Cramer Won’t Buy Apple Stock at Current Prices Unless the Company Does This
Mar-14-19 09:36AM Tandem Diabetes (TNDM) Hits a 52-Week High on Solid Prospects
Mar-11-19 02:25PM Tandem Diabetes Signs as an Insulin Pump Vendor in Canada
09:01AM Why Tandem Diabetes Care Stock Soared 51% in February
Mar-07-19 04:15PM Tandem Diabetes Care Approved as Insulin Pump Vendor for ADP in Ontario, Canada

However, when making a decision to invest, investors should look at far more than just news, especially in the ever changing technology industry. Here’s what’s happing when it comes to Tandem Diabetes Care, Inc..

The Performance That We’ve Seen From TNDM

Although a move down in a single session, like what we’re seeing from Tandem Diabetes Care, Inc. might cause fear in some investors, a single session fall by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s always important to look into trends for a period longer than a single trading session. When it comes to TNDM, here are the trends that we’ve seen:

  • Past 5 Sessions – In the past five trading sessions, TNDM has seen a change in value amounting to -6.00%.
  • Monthly – The monthly returns from Tandem Diabetes Care, Inc. comes to 40.13%.
  • Past Three Months – Throughout the last quarter, the stock has produced a return that works out to 109.76%
  • Bi-Annually – In the past six months, we have seen a change of 72.12% from the company.
  • YTD – Since the open of this year TNDM has produced a return of 81.09%.
  • Full Year – Finally, over the last full year, we’ve seen performance of 1758.38% out of TNDM. Throughout this period of time, the stock has sold at a high of -8.09% and a low of 1783.32%.

Crucial Ratios

Looking at various ratios associated with a company can give prospective traders a look of just how risky and/or potentially profitable a an investment option might be. Here are some of the important ratios to look at when digging into TNDM.

Short Ratio – The short ratio is a measure of short interest. As the ratio climbs, it means that more investors have a belief that the stock is going to fall. In general, strong technology stocks can come with a lower short ratio. On the other hand, we tend to see a lot of short squeezes in the sector. Nonetheless, in regard to Tandem Diabetes Care, Inc., the stock’s short ratio amounts to 2.97.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Basically, they measure whether or not a company can pay for its debts when they mature based on quick assets or current assets. Because in tech, companies rely on the continuation of investor support as they work to bring new technologies to market, the quick and current ratios can seem bad. Nonetheless, quite a few better companies in the tech space come with good current and quick ratios. As far as TNDM, the quick and current ratios add up to 2.50 and 2.80 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets owned by the company. In this case, the book to share value ratio comes in at 2.28.

Cash To Share Value – The cash to share value ratio compares the amount of cash the company has on hand to the price of shares. In this case, the cash to share value ratio comes to 2.27.

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TNDM, here’s what we’re seeing:

Institutions own 88.40% of the company. Institutional interest has moved by 15.21% over the past three months. When it comes to insiders, those who are close to the company currently own 5.12% percent of TNDM shares. Institutions have seen ownership changes of an accumulative -18.36% over the last three months.

What Analysts Say About Tandem Diabetes Care, Inc.

Although it’s never a good idea to unknowingly follow the thoughts of analysts, it is a good idea to consider their analysis in order to validate your own before making investment decisions in the technology industry. Below are the recent moves that we have seen from analysts with regard to TNDM.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-08-19 Initiated BMO Capital Markets Outperform $77
Mar-05-19 Reiterated BofA/Merrill Neutral $59 → $65
Feb-27-19 Reiterated Lake Street Buy $60 → $100
Nov-21-18 Upgrade Robert W. Baird Neutral → Outperform
Sep-26-18 Reiterated Piper Jaffray Overweight $32 → $56

What We’ve Seen In earnings results

What have ween seen from TNDM in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts are expecting that Tandem Diabetes Care, Inc. will create earnings per diluted share that comes to -0.39, with -0.30 to be announced in the report for the current quarter. Although this data is not based on earnings, since we’re talking about Wall St. analysts, the stock is presently rated a 2.00 when rated on a scale from 1 to 5 where 1 is the worst possible Wall St. analyst grade and 5 is the best possible rating.
  • 5-Year Sales – In the past half decade, Tandem Diabetes Care, Inc. has generated a movement in sales volume in the amount of 44.70%. Earnings per share through the last half decade have generated movement in the amount of 37.90%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings data, or Q/Q data as it is often represented in the world of humans, TNDM has experienced a earnings change by 100.90%. Tandem Diabetes Care, Inc. has also experienced movement when it comes to sales volume in the amount of 89.10%.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 56.79M shares of Tandem Diabetes Care, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TNDM has a float of 53.15M.

I also like to look at the short float. After all, when a high portion of the float available for trading is sold short, the overall feeling in the market is that the stock is going to fall. As far as TNDM, the short percentage of the float is currently 11.22%. Most investors would say that a high short percent of the float is anything over 40%. Nonetheless, I have found that anything over 26% is likely a risky play.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. However, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I learn much faster when I have a teacher. If you’d like to help me learn something, I’d love to learn! Is there other data that you’re interested in? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here